Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1977 1
1982 1
1983 2
1985 5
1986 5
1987 3
1988 2
1989 8
1990 11
1991 14
1992 11
1993 30
1994 27
1995 30
1996 40
1997 41
1998 62
1999 38
2000 65
2001 57
2002 61
2003 62
2004 83
2005 76
2006 69
2007 82
2008 55
2009 51
2010 62
2011 75
2012 78
2013 78
2014 75
2015 80
2016 75
2017 67
2018 64
2019 70
2020 79
2021 88
2022 73
2023 67
2024 24

Text availability

Article attribute

Article type

Publication date

Search Results

1,824 results

Results by year

Filters applied: . Clear all
Quoted phrase not found in phrase index: "Transplant-Related Disorder"
Page 1
Organ transplant-related lymphoma.
Swinnen LJ. Swinnen LJ. Curr Treat Options Oncol. 2001 Aug;2(4):301-8. doi: 10.1007/s11864-001-0023-7. Curr Treat Options Oncol. 2001. PMID: 12057110 Review.
Post-transplant lymphoproliferative disorder is a curable disease in which a wide range of treatment strategies has met with a degree of success. Both the disease and the organ transplant setting in which it occurs are highly variable. ...
Post-transplant lymphoproliferative disorder is a curable disease in which a wide range of treatment strategies has met with a …
Allogeneic hematopoietic cell transplantation in acute myeloid leukemia.
Magee G, Ragon BK. Magee G, et al. Best Pract Res Clin Haematol. 2023 Jun;36(2):101466. doi: 10.1016/j.beha.2023.101466. Epub 2023 Apr 6. Best Pract Res Clin Haematol. 2023. PMID: 37353286 Review.
Allogeneic hematopoietic cell transplantation (HCT) is a curative treatment modality for select patients with acute myeloid leukemia (AML), functioning as a restorative agent following intensified chemo- and/or radiotherapy and also engendering the disease-directed immunol …
Allogeneic hematopoietic cell transplantation (HCT) is a curative treatment modality for select patients with acute myeloid leukemia (AML), …
Acute Graft-versus-Host Disease: An Update on New Treatment Options.
Patel DA, Crain M, Pusic I, Schroeder MA. Patel DA, et al. Drugs. 2023 Jul;83(10):893-907. doi: 10.1007/s40265-023-01889-2. Epub 2023 May 29. Drugs. 2023. PMID: 37247105 Review.
Acute graft-versus-host disease (GVHD) occurs in approximately 50% of patients and remains a primary driver of non-relapse and transplant-related mortality. The best treatment remains prevention with either in vivo or ex vivo T-cell depletion, with multiple s …
Acute graft-versus-host disease (GVHD) occurs in approximately 50% of patients and remains a primary driver of non-relapse and tra …
Real-world evidence of the safety and survival with CD19 CAR-T cell therapy for relapsed/refractory solid organ transplant-related PTLD.
McKenna M, Epperla N, Ghobadi A, Liu J, Lazaryan A, Ibrahim U, Jacobson CA, Naik SG, Nastoupil L, Chowdhury SM, Voorhees TJ, Jacobs MT, Farooq U, Osman K, Olszewski AJ, Ahmed S, Evens AM. McKenna M, et al. Br J Haematol. 2023 Jul;202(2):248-255. doi: 10.1111/bjh.18828. Epub 2023 May 2. Br J Haematol. 2023. PMID: 37129856
The use of CD19 chimeric antigen receptor T-cell (CAR-T) therapy for relapsed/refractory solid organ transplantation (SOT)-related post-transplant lymphoproliferative disorder (PTLD) is not well studied. We conducted a multicentre, retrospective analysis of adults with rel …
The use of CD19 chimeric antigen receptor T-cell (CAR-T) therapy for relapsed/refractory solid organ transplantation (SOT)-related post-tran …
Novel therapeutics and targets in myelofibrosis.
Waksal JA, Harrison CN, Mascarenhas JO. Waksal JA, et al. Leuk Lymphoma. 2022 May;63(5):1020-1033. doi: 10.1080/10428194.2021.2010068. Epub 2021 Dec 2. Leuk Lymphoma. 2022. PMID: 34852713 Review.
Allogeneic hematopoietic stem cell transplantation (aHCT) is the only curative therapy for patients with MF; however, transplant-related morbidity and mortality precludes this option for the majority of patients. ...In this review, we discuss the limitations of curr …
Allogeneic hematopoietic stem cell transplantation (aHCT) is the only curative therapy for patients with MF; however, transplant-r …
Therapy-related myeloid neoplasms: pathobiology and clinical characteristics.
Sill H, Olipitz W, Zebisch A, Schulz E, Wölfler A. Sill H, et al. Br J Pharmacol. 2011 Feb;162(4):792-805. doi: 10.1111/j.1476-5381.2010.01100.x. Br J Pharmacol. 2011. PMID: 21039422 Free PMC article. Review.
Prognosis of patients with t-MNs is dismal and at present, the only curative approach for the majority of these individuals is haematopoietic stem cell transplantation, which is characterized by high transplant-related mortality rates. Novel transplantation strategi …
Prognosis of patients with t-MNs is dismal and at present, the only curative approach for the majority of these individuals is haematopoieti …
Consolidation Therapy in Primary Central Nervous System Lymphoma.
Kim P, Omuro A. Kim P, et al. Curr Treat Options Oncol. 2020 Jul 28;21(9):74. doi: 10.1007/s11864-020-00758-4. Curr Treat Options Oncol. 2020. PMID: 32725379 Review.
Primary central nervous system lymphoma is a complex disease with no agreed-upon standard-of-care therapy. Induction therapy involves multiagent chemotherapy based on high-dose methotrexate, with several regimens available. ...For patients who are not transplant candidates …
Primary central nervous system lymphoma is a complex disease with no agreed-upon standard-of-care therapy. Induction therapy involves …
Peripheral Vascular Disease and Kidney Transplant Outcomes: Rethinking an Important Ongoing Complication.
Hernández D, Vázquez T, Armas-Padrón AM, Alonso-Titos J, Casas C, Gutiérrez E, Jironda C, Cabello M, López V. Hernández D, et al. Transplantation. 2021 Jun 1;105(6):1188-1202. doi: 10.1097/TP.0000000000003518. Transplantation. 2021. PMID: 33148978 Review.
Peripheral vascular disease (PVD) is highly prevalent in patients on the waiting list for kidney transplantation (KT) and after transplantation and is associated with impaired transplant outcomes. Multiple traditional and nontraditional risk factors, as well as uremia- and …
Peripheral vascular disease (PVD) is highly prevalent in patients on the waiting list for kidney transplantation (KT) and after trans …
Microbiome Anomalies in Allogeneic Hematopoietic Cell Transplantation.
Schwabkey ZI, Jenq RR. Schwabkey ZI, et al. Annu Rev Med. 2020 Jan 27;71:137-148. doi: 10.1146/annurev-med-052918-122440. Annu Rev Med. 2020. PMID: 31986084 Free PMC article. Review.
The microbiome is an integrated part of the human body that can modulate a variety of disease processes and affect prognosis, treatment response, complications, and outcomes. The importance of allogeneic hematopoietic cell transplantation in cancer treatment has resulted i …
The microbiome is an integrated part of the human body that can modulate a variety of disease processes and affect prognosis, treatme …
1,824 results